Prevalence of chronic hepatitis B infection in Iran: a review article

<font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><ul><li><div align="left">Hepatitis B virus infection is a major public health problem worldwide. Islamic Re...

Full description

Bibliographic Details
Main Authors: Jalal Poorolajal, Reza Majdzadeh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2009-08-01
Series:Journal of Research in Medical Sciences
Subjects:
Online Access:http://journals.mui.ac.ir/jrms/article/view/2714
id doaj-d59adfb25d3a4dae9106d83c61465c18
record_format Article
spelling doaj-d59adfb25d3a4dae9106d83c61465c182020-11-24T21:22:18ZengWolters Kluwer Medknow PublicationsJournal of Research in Medical Sciences1735-19951735-71362009-08-01144249258Prevalence of chronic hepatitis B infection in Iran: a review articleJalal PoorolajalReza Majdzadeh<font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><ul><li><div align="left">Hepatitis B virus infection is a major public health problem worldwide. Islamic Republic of Iran is a country in which hepatitisB prevalence is intermediate. The aim of this study is to assess prevalence of chronic hepatitis B infection in Iran according to demographic characteristics. All cross-sectional studies concerning  revalence of chronic hepatitis B infection in Iran were included irrespective of date and language. The outcome of interest was prevalence of chronic hepatitis B infection confirmed by blood specimen positive for HBsAg. The prevalence of chronic hepatitis B infection was  stimated about 1.7% or lower in general population; 0.8% (95% CI: 0.6% to 0.9%) in blood donors and 3.2% (95% CI: 2.3% to 4.1%) in intravenous drug users and varied from zero to 1.5% in beta thalassemic patients. Since mass vaccination in 1993, prevalence of chronic hepatitis B infection has being reduced among children and adolescents. This reduction can be attributed to the effectiveness of the national immunization program and it may impact on reduction of prevalence of hepatitis B infection in general population.</div></li><font face="TimesNewRoman,Bold" size="1"><font face="TimesNewRoman,Bold" size="1"><li><div align="left"><strong>KEY WORDS:</strong> <font face="BookAntiqua" size="2"><font face="BookAntiqua" size="2">Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran</font></font><font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><strong>.</strong></font></font></div></li></font></font></ul></font></font> http://journals.mui.ac.ir/jrms/article/view/2714Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran.
collection DOAJ
language English
format Article
sources DOAJ
author Jalal Poorolajal
Reza Majdzadeh
spellingShingle Jalal Poorolajal
Reza Majdzadeh
Prevalence of chronic hepatitis B infection in Iran: a review article
Journal of Research in Medical Sciences
Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran.
author_facet Jalal Poorolajal
Reza Majdzadeh
author_sort Jalal Poorolajal
title Prevalence of chronic hepatitis B infection in Iran: a review article
title_short Prevalence of chronic hepatitis B infection in Iran: a review article
title_full Prevalence of chronic hepatitis B infection in Iran: a review article
title_fullStr Prevalence of chronic hepatitis B infection in Iran: a review article
title_full_unstemmed Prevalence of chronic hepatitis B infection in Iran: a review article
title_sort prevalence of chronic hepatitis b infection in iran: a review article
publisher Wolters Kluwer Medknow Publications
series Journal of Research in Medical Sciences
issn 1735-1995
1735-7136
publishDate 2009-08-01
description <font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><ul><li><div align="left">Hepatitis B virus infection is a major public health problem worldwide. Islamic Republic of Iran is a country in which hepatitisB prevalence is intermediate. The aim of this study is to assess prevalence of chronic hepatitis B infection in Iran according to demographic characteristics. All cross-sectional studies concerning  revalence of chronic hepatitis B infection in Iran were included irrespective of date and language. The outcome of interest was prevalence of chronic hepatitis B infection confirmed by blood specimen positive for HBsAg. The prevalence of chronic hepatitis B infection was  stimated about 1.7% or lower in general population; 0.8% (95% CI: 0.6% to 0.9%) in blood donors and 3.2% (95% CI: 2.3% to 4.1%) in intravenous drug users and varied from zero to 1.5% in beta thalassemic patients. Since mass vaccination in 1993, prevalence of chronic hepatitis B infection has being reduced among children and adolescents. This reduction can be attributed to the effectiveness of the national immunization program and it may impact on reduction of prevalence of hepatitis B infection in general population.</div></li><font face="TimesNewRoman,Bold" size="1"><font face="TimesNewRoman,Bold" size="1"><li><div align="left"><strong>KEY WORDS:</strong> <font face="BookAntiqua" size="2"><font face="BookAntiqua" size="2">Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran</font></font><font face="TimesNewRoman" size="2"><font face="TimesNewRoman" size="2"><strong>.</strong></font></font></div></li></font></font></ul></font></font>
topic Hepatitis B, Prevalence, Blood Donors, Thalassemia, Drug Users, Iran.
url http://journals.mui.ac.ir/jrms/article/view/2714
work_keys_str_mv AT jalalpoorolajal prevalenceofchronichepatitisbinfectioniniranareviewarticle
AT rezamajdzadeh prevalenceofchronichepatitisbinfectioniniranareviewarticle
_version_ 1725996344896651264